In the present study, miR-185-3p, as a functional cargo miRNA within the HNSCC cells-derived exosomes, was increased and therefore regulating the expression of RAB25, suggesting miR-185-3p/RAB25 signaling serves as novel target for HNSCC treatment. The gene discussed is RAB25; the disease is head and neck squamous cell carcinoma.